Lo Presti, C.; Yamaryo-Botté, Y.; Mondet, J.; Berthier, S.; Nutiu, D.; Botté, C.; Mossuz, P.
Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients. Int. J. Mol. Sci. 2023, 24, 5988.
https://doi.org/10.3390/ijms24065988
AMA Style
Lo Presti C, Yamaryo-Botté Y, Mondet J, Berthier S, Nutiu D, Botté C, Mossuz P.
Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients. International Journal of Molecular Sciences. 2023; 24(6):5988.
https://doi.org/10.3390/ijms24065988
Chicago/Turabian Style
Lo Presti, Caroline, Yoshiki Yamaryo-Botté, Julie Mondet, Sylvie Berthier, Denisa Nutiu, Cyrille Botté, and Pascal Mossuz.
2023. "Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients" International Journal of Molecular Sciences 24, no. 6: 5988.
https://doi.org/10.3390/ijms24065988
APA Style
Lo Presti, C., Yamaryo-Botté, Y., Mondet, J., Berthier, S., Nutiu, D., Botté, C., & Mossuz, P.
(2023). Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients. International Journal of Molecular Sciences, 24(6), 5988.
https://doi.org/10.3390/ijms24065988